Whether it’s due to all the brainwashing from Netflix documentaries, or just down to better access to information, consumers are way more informed when it comes to health, especially in terms of nutrition. And as you’d expect, businesses – be it big time brands or small, independents or startups – have caught on. As a result, there… Read More »
The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup. Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »
This week there are a series of articles related to the recommendations issued by the US Preventive Services Task Force (USPSTF) several weeks ago, stating that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and recommends that women at increased risk for perinatal depression should be referred… Read More »